Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
![Allergy-pollen[optimized]](https://www.pharm-olam.com/hs-fs/hubfs/assets/images/Pages/Case%20Studies/Allergy/Allergy-pollen%5Boptimized%5D.jpg?width=1020&height=765&name=Allergy-pollen%5Boptimized%5D.jpg)
Pharm-Olam was contracted to provide a full-service solution for two Phase II, dose escalation allergy studies that required a total of 500 patients in Europe and were run in parallel. With two different indications required, Grass Pollen Allergy and Birch Pollen Allergy, Pharm-Olam delivered both studies on time. Learn more these two trials in this case study.
Allergy shots decrease sensitivity to allergens and often leads to lasting relief of allergy symptoms even after treatment is stopped. This makes it a modern, beneficial and cost-effective treatment approach for many people.
84% Project Management Experience
86% CRA Allergy Experience
Studies with pediatric and adolescent populations are very different from clinical research with adult populations. Choose an Allergy CRO that has the experience to overcome these challenges.
Successfully completing allergy studies requires more than agility and ownership. For many allergy conditions, seasonality is a factor so studies must be completed within a specific timeframe.
Allergy Studies Include:
Perennial allergies present their own challenges. They often present with other allergies, so finding patients that present with monoallergies is critical to determine true efficacy.
Allergies Include:
At Pharm-Olam, we’re here to help. Our experienced global staff has extensive experience in the processing and management of allergy clinical trials.
Watch the Video
Pharm-Olam was contracted to assess subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.
Learn More